This inventor holds 1 USPTO granted patent. Top assignee: Pharmachim. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Dobrinka G Gentcheva: Innovator in Glaucoma Treatment
Introduction
Dobrinka G Gentcheva is a notable inventor based in Sofia, Bulgaria. She has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. Her innovative work has led to the development of a unique composition aimed at alleviating this serious eye condition.
Latest Patents
Dobrinka holds 1 patent for her invention titled "Composition and method for treating glaucoma." This antiglaucoma composition features an active component, specifically a s-/-/-2,3 dihydroxy-9,10,11-trimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo (a,f) quinolizine hydrochloride. The composition is designed to be used as an ophthalmic solution, administered in therapeutic doses of 2 to 3 drops two to four times daily to warm-blooded animals suffering from glaucoma.
Career Highlights
Dobrinka is currently associated with Pharmachim, a company known for its pharmaceutical innovations. Her work at Pharmachim has allowed her to focus on developing effective treatments for various medical conditions, including glaucoma.
Collaborations
Dobrinka has collaborated with several professionals in her field, including Marko T Markov and Chavdar B Ivanov. These collaborations have contributed to her research and development efforts, enhancing the impact of her inventions.
Conclusion
Dobrinka G Gentcheva's contributions to glaucoma treatment exemplify the importance of innovation in healthcare. Her dedication to developing effective solutions showcases her commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile